IFNA1 and Graves disease: The fact that Graves' Disease, which is thought to be due to a Th2 mediated production of stimulating TRAb, is much less common in IFN-α treated patients suggests that IFN-α preferentially activates Th1 immunity which in turn leads to the higher rate of destructive thyroiditis seen in these patients.